CC-90010
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CC-90010, covering 2024-07-05 to 2024-10-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas [Phase 1]